Mike Broughton

Director, Global Logistics
Eli Lilly

Mike Broughton is the Director for Global Logistics. In this role, he will serve as the global process owner for pharmaceutical logistics. Responsibilities include developing a strategy and organizational structure for the internal and external distribution networks encompassing global operational polices and standards. Mike has over 28 years of experience in the pharmaceutical industry including 24 years at Eli Lilly. During this time, he has held several positions ranging from pharmaceutical engineering, sterile product operations management, global manufacturing strategy and supply chain leadership in the United Kingdom. Mike received his BSEE degree from the University of Missouri and a MBA from Indiana University.

Check out the incredible speaker line-up to see who will be joining Mike.

Download The Latest Agenda

Conference day one – Tuesday 19 April 2016

Tuesday, July 4th, 2017

11:55 How to create a corporate action plan to ensure EU GDP guidelines post-Jan 2016 are met across the business

Mike is the global process owner for logistics - directly responsible for serving as the global process owner for warehouse, shipping and distribution operations. He is in charge of developing strategy and organizational structure for the internal and external distribution networks encompassing global operational polices and standards. Mike has over 25 years of experience in the pharmaceutical industry including 22 years at Eli Lilly, ideally placing him to discuss the best strategies for governance of providers.

•How to prioritise what to include in the corporate action plan •What strategies can you put in place to minimise misinterpretations of the plan?
•What should you prioritise to remain compliant whilst controlling cost?
•How can you encourage buy-in from key stakeholders across the business?

Conference day two - Wednesday 20 April 2016

Friday, August 4th, 2017

09:00 ALL STAR PANEL: How can you influence senior management and the commercial team to implement a new segmentation strategy and add commercial value to the business?

A truly engaging panel of pharma supply chain leaders discuss their latest strategies to increase put supply chain towards the forefront within their company.
• To what extent can segmentation significantly improve customer service and can it really add commercial value?
• How can supply chain influence the commercial team to implement a segmented strategy?
• How can you make sure segmentation will reduce costs to ensure it is really worth the investment?
• What can pharma learn from FMCG in segmentation through distribution channels?